Literature DB >> 18980264

A direct comparison of effect sizes from the clinical global impression-improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder.

Dawson W Hedges1, Bruce L Brown, David A Shwalb.   

Abstract

OBJECTIVE: The clinical global impression-improvement scale (CGI-I) is used to monitor treatment outcome in mental disorders. To better understand the properties of the CGI-I scale in social anxiety disorder, effects sizes from the CGI-I scale were compared to comparably calculated effect sizes from other rating scales obtained from double-blind, placebo-controlled trials of selective-serotonin reuptake inhibitors in social anxiety disorder. From peer-reviewed, double-blind, placebo-controlled studies evaluating selective serotonin reuptake inhibitors in social anxiety disorder, we extracted CGI-I data and scores from other assessment scales of severity and function. Using calculations that enabled direct comparisons, effect sizes for the binarily reported CGI-I scores were compared to effect sizes from the quantitative scales.
RESULTS: Effect sizes for the binary CGI-I scale were statistically indistinguishable from effect sizes obtained from the other scales, with the exception of the social avoidance and distress scale.
CONCLUSIONS: The CGI-I scale is an appropriate method of assessing clinical change in trials of social anxiety disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18980264     DOI: 10.1002/hup.989

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  12 in total

1.  Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials.

Authors:  Gabriela Bezerra de Menezes; Evandro Silva Freire Coutinho; Leonardo F Fontenelle; Paula Vigne; Ivan Figueira; Márcio Versiani
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

2.  Assessing Clinical Improvement in School-Based Treatment for Social Anxiety Disorder: Agreement Between Adolescents, Parents, and Independent Evaluators.

Authors:  Jeremy K Fox; Carrie Masia Warner
Journal:  Child Psychiatry Hum Dev       Date:  2017-10

3.  Quality measures for the care of patients with insomnia.

Authors:  Jack D Edinger; Daniel J Buysse; Ludmila Deriy; Anne Germain; Daniel S Lewin; Jason C Ong; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

Review 4.  S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.

Authors:  Anup Sharma; Patricia Gerbarg; Teodoro Bottiglieri; Lila Massoumi; Linda L Carpenter; Helen Lavretsky; Philip R Muskin; Richard P Brown; David Mischoulon
Journal:  J Clin Psychiatry       Date:  2017-06       Impact factor: 4.384

5.  Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.

Authors:  Jack D Edinger; Rachel Manber; Daniel J Buysse; Andrew D Krystal; Michael E Thase; Phillip Gehrman; Christopher P Fairholme; James Luther; Stephen Wisniewski
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

6.  The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial.

Authors:  Tamar Green; Lital Steingart; Amos Frisch; Omer Zarchi; Abraham Weizman; Doron Gothelf
Journal:  J Neural Transm (Vienna)       Date:  2012-06-08       Impact factor: 3.575

7.  Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine.

Authors:  Sarah W Book; Suzanne E Thomas; Joshua P Smith; Patrick K Randall; Matt G Kushner; Gail A Bernstein; Sheila M Specker; Peter M Miller; Carrie L Randall
Journal:  J Anxiety Disord       Date:  2013-03-04

8.  Response to intravenous fentanyl infusion predicts subsequent response to transdermal fentanyl.

Authors:  Norihito Hayashi; Akifumi Kanai; Asaha Suzuki; Yuki Nagahara; Hirotsugu Okamoto
Journal:  J Anesth       Date:  2015-12-11       Impact factor: 2.078

9.  The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome.

Authors:  Thomas Forkmann; Anne Scherer; Maren Boecker; Markus Pawelzik; Ralf Jostes; Siegfried Gauggel
Journal:  BMC Psychiatry       Date:  2011-05-14       Impact factor: 3.630

10.  Simultaneous synthesis of treatment effects and mapping to a common scale: an alternative to standardisation.

Authors:  A E Ades; Guobing Lu; Sofia Dias; Evan Mayo-Wilson; Daphne Kounali
Journal:  Res Synth Methods       Date:  2015-01-23       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.